Liu Jun, Niu Yu-Guang, Li Wan-Xin, Yuan Yong-Yi, Han Wei-Ju, Yu Ning, Yang Shi-Ming, Li Xing-Qi
Department of Otolaryngology Head and Neck Surgery, Institute of Otolaryngology, Chinese PLA General Hospital, Beijing, PR China.
Acta Otolaryngol. 2012 Nov;132(11):1140-4. doi: 10.3109/00016489.2012.690534. Epub 2012 Jul 10.
Both nifedipine and noise exposure had damaging effects on cochlear function. These damaging effects were subtractive rather than additive, suggesting that calcium channel blockers may have a protective role in noise-induced hearing loss.
We assessed the interaction of nifedipine, a calcium channel blocker, with noise in cochlear function by evaluating changes in the compound action potential (CAP) threshold after the administration of nifedipine with or without noise exposure.
Eighty guinea pigs were randomly assigned to eight groups based on those with cochlear perfusion with nifedipine only (0, 0.15, 0.5, and 3 µM, groups 1-4) and noise exposure (groups 5-8). CAP thresholds were recorded using a round window electrode before and 120 min after cochlear perfusion.
Cochlear perfusion of different concentrations of nifedipine caused 2.5, 5.5, 28, and 21.5 dB SPL threshold shift, respectively, at 0, 0.15, 0.5, and 3 µM concentrations (groups 1-4). In comparison, the CAP thresholds after nifedipine perfusion with noise exposure were 43.5, 46.5, 20, and 21.5 dB SPL, respectively, in groups 5-8.
硝苯地平和噪声暴露均对耳蜗功能有损害作用。这些损害作用是相减而非相加的,提示钙通道阻滞剂可能在噪声性听力损失中具有保护作用。
我们通过评估在有或无噪声暴露情况下给予硝苯地平后复合动作电位(CAP)阈值的变化,来评估钙通道阻滞剂硝苯地平与噪声在耳蜗功能方面的相互作用。
80只豚鼠根据是否仅进行耳蜗灌注硝苯地平(0、0.15、0.5和3μM,第1 - 4组)以及是否有噪声暴露(第5 - 8组)被随机分为8组。在耳蜗灌注前及灌注后120分钟,使用圆窗电极记录CAP阈值。
在第1 - 4组中,不同浓度硝苯地平的耳蜗灌注分别在0、0.15、0.5和3μM浓度下导致2.5、5.5、28和21.5 dB SPL的阈值偏移。相比之下,在第5 - 8组中,硝苯地平灌注加噪声暴露后的CAP阈值分别为43.5、46.5、20和21.5 dB SPL。